Authors:
DELORENZO F
XIAO H
MUKHERJEE M
HARCUP J
SULEIMAN S
KADZIOLA Z
KAKKAR VV
Citation: F. Delorenzo et al., CHRONIC-FATIGUE-SYNDROME - PHYSICAL AND CARDIOVASCULAR DECONDITIONING, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(7), 1998, pp. 475-481
Authors:
DELORENZO F
MUKHERJEE M
KADZIOLA Z
KAKKAR VV
Citation: F. Delorenzo et al., ASSOCIATION OF DEXA-ASSESSED TOTAL-BODY FAT MASS WITH SERUM-LIPIDS AND HEMOSTATIC VARIABLES, Blood coagulation & fibrinolysis, 9(3), 1998, pp. 291-292
Authors:
DELORENZO F
MUKHERJEE M
KADZIOLA Z
SULEIMAN S
KAKKAR VV
Citation: F. Delorenzo et al., ASSOCIATION OF OVERALL ADIPOSITY RATHER THAN BODY-MASS INDEX WITH LIPIDS AND PROCOAGULANT FACTORS, Thrombosis and haemostasis, 80(4), 1998, pp. 603-606
Authors:
PATEL Y
RAHMAN S
SIDDIQUA A
WILKINSON JM
KAKKAR VV
AUTHI KS
Citation: Y. Patel et al., FUNCTIONAL-CHARACTERIZATION OF PM6 13, A BETA(3)-SPECIFIC (GPIIIA/CD61) MONOCLONAL-ANTIBODY THAT SHOWS PREFERENTIAL INHIBITION OF FIBRINOGEN BINDING OVER FIBRONECTIN-BINDING TO ACTIVATED HUMAN PLATELETS/, Thrombosis and haemostasis, 79(1), 1998, pp. 177-185
Citation: Ms. Mohamed et al., THROMBOGENICITY OF HEPARIN AND NON-HEPARIN BOUND ARTERIAL PROSTHESES - AN IN-VITRO EVALUATION, Journal of the Royal College of Surgeons of Edinburgh, 43(3), 1998, pp. 155-157
Authors:
SHARMA V
EDMEAD C
KADZIOLA Z
HEATON N
GIBBS P
KAKKAR VV
Citation: V. Sharma et al., PREVENTION OF APOPTOSIS IN INTERFERON GAMMA-ACTIVATED ENDOTHELIAL-CELLS WITH HEPARIN TREATMENT, British Journal of Surgery, 85(11), 1998, pp. 1583-1583
Authors:
SKORDALAKES E
ELGENDY S
GOODWIN CA
GREEN D
SCULLY MF
KAKKAR VV
FREYSSINET JM
DODSON G
DEADMAN JJ
Citation: E. Skordalakes et al., BIFUNCTIONAL PEPTIDE BORONATE INHIBITORS OF THROMBIN - CRYSTALLOGRAPHIC ANALYSIS OF INHIBITION ENHANCED BY LINKAGE TO AN EXOSITE-1 BINDING PEPTIDE, Biochemistry (Easton), 37(41), 1998, pp. 14420-14427
Citation: A. Siddiqua et al., PURIFICATION OF A NOVEL SERCA CA2-LINE DAMI( ATPASE FROM HUMAN PLATELETS AND THE MEGAKARYOCYTIC CELL), Acta Physiologica Scandinavica, 163, 1998, pp. 339-339
Authors:
LUPU C
GOODWIN CA
WESTMUCKETT AD
EMEIS JJ
SCULLY MF
KAKKAR VV
LUPU F
Citation: C. Lupu et al., TISSUE FACTOR PATHWAY INHIBITOR IN ENDOTHELIAL-CELLS COLOCALIZES WITHGLYCOLIPID MICRODOMAINS CAVEOLAE - REGULATORY MECHANISM(S) OF THE ANTICOAGULANT PROPERTIES OF THE ENDOTHELIUM/, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 2964-2974
Authors:
KEOGH MC
CHEN D
LUPU F
SHAPER N
SCHMITT JF
KAKKAR VV
LEMOINE NR
Citation: Mc. Keogh et al., HIGH-EFFICIENCY REPORTER GENE TRANSFECTION OF VASCULAR TISSUE IN-VITRO AND IN-VIVO USING A CATIONIC LIPID-DNA COMPLEX, Gene therapy, 4(2), 1997, pp. 162-171
Citation: A. Siddiqua et al., PURIFICATION OF A NOVEL SERCA CA2-LINE DAMI( ATPASE FROM HUMAN PLATELETS AND THE MEGAKARYOCYTIC CELL), The FASEB journal, 11(9), 1997, pp. 663-663
Authors:
ELDAHER SS
WOJCIKIEWICZ RJH
KAKKAR VV
AUTHI KS
Citation: Ss. Eldaher et al., INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS IN PLATELET MEMBRANES - LOCALIZATION AND PHOSPHORYLATION BY PROTEIN-KINASE-A, The FASEB journal, 11(9), 1997, pp. 1163-1163
Authors:
KAKKAR VV
BOECKL O
BONEU B
BORDENAVE L
BREHM OA
BRUCKE P
COCCHERI S
COHEN AT
GALLAND F
HAAS S
JARRIGE J
KOPPENHAGEN K
LEQUERREC A
PARRAGUETTE E
PRANDONI P
RODER JD
ROOS M
RUSCHEMEYER C
SIEWERT JR
VINAZZER H
WENZEL E
Citation: Vv. Kakkar et al., EFFICACY AND SAFETY OF A LOW-MOLECULAR-WEIGHT HEPARIN AND STANDARD UNFRACTIONATED HEPARIN FOR PROPHYLAXIS OF POSTOPERATIVE VENOUS THROMBOEMBOLISM - EUROPEAN MULTICENTER TRIAL, World journal of surgery, 21(1), 1997, pp. 2-9
Authors:
ESMAIL AF
DUPE RJ
GODDARD M
BRIGGS I
LUPU F
KAKKAR VV
Citation: Af. Esmail et al., COMPARISION OF ANTITHROMBOTIC PROPERTIES OF TRIBAN, HIRUDIN, HEPARIN AND ASPIRIN IN A NEW DYNAMIC-MODEL OF VENOUS THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 368-368
Authors:
LU X
PRESSDEE L
RAHMAN S
KAKKAR VV
AUTHI KS
Citation: X. Lu et al., FUNCTIONAL-STUDIES OF 3 ARGDN-CONTAINING SNAKE-VENOM PROTEINS ON PLATELET-ADHESION TO GLYCOPROTEINS, Thrombosis and haemostasis, 1997, pp. 1390-1390
Citation: C. Kanthou et al., INTERACTIONS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) WITH HUMAN VASCULAR SMOOTH-MUSCLE CELLS, Thrombosis and haemostasis, 1997, pp. 1635-1635
Authors:
LUPU C
WESTMUCKETT A
GOODWIN C
EMEIS J
KAKKAR VV
LUPU F
Citation: C. Lupu et al., ASSOCIATION OF CELLULAR TISSUE FACTOR PATHWAY INHIBITOR WITH CAVEOLAEGLYCOLIPID MICRODOMAINS MEDIATES UP-REGULATION OF ENDOTHELIAL-CELLS ANTICOAGULANT PROPERTIES/, Thrombosis and haemostasis, 1997, pp. 1660-1660
Citation: M. Mukherjee et Vv. Kakkar, THE C-TERMINUS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) MODULATES TRIGLYCERIDE-METABOLISM BY ENHANCING THE ACTIVITY OF LIPOPROTEIN-LIPASE (LPL), Thrombosis and haemostasis, 1997, pp. 1661-1661
Citation: J. Crawley et al., IN-SITU EXPRESSION OF TISSUE FACTOR PATHWAY INHIBITOR MESSENGER-RNA AND ANTIGEN IN ADVANCED HUMAN ATHEROSCLEROTIC LESIONS, Thrombosis and haemostasis, 1997, pp. 1664-1664
Authors:
DEADMAN JJ
SKORDALAKES E
ELGENDY S
GREEN D
GOODWIN CA
CLAESON G
SCULLY MF
KAKKAR VV
GAMBLIN S
DODSON G
Citation: Jj. Deadman et al., ELUCIDATION OF THE THROMBIN INHIBITORY MECHANISM OF TRIPEPTIDE BORONATES WITH NEUTRAL P1 SIDE-CHAINS, Thrombosis and haemostasis, 1997, pp. 2024-2024
Authors:
ESMAIL AF
SCULLY MF
DUPE RJ
DEADMAN JJ
GOODWIN CG
BRIGGS IM
GODDARD M
KAKKAR VV
Citation: Af. Esmail et al., EFFECT OF TRIBAN A NOVEL THROMBIN INHIBITOR ON PLATELET PROCOAGULANT ACTIVITY IN-VITRO AND SK INDUCED THROMBOLYSIS IN-VIVO, Thrombosis and haemostasis, 1997, pp. 2037-2037
Authors:
BENZAKOUR O
KANTHOU C
KANSE SM
GLEIG F
DAHLBACK B
PREISSNER KT
KAKKAR VV
Citation: O. Benzakour et al., INDUCTION OF HUMAN VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION BY PROTEIN-S - BINDING-STUDIES AND MECHANISM OF ACTION, Thrombosis and haemostasis, 1997, pp. 2278-2278